ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs
The dataset powers our Rx Inspector tool, which lets you find the factories that made your generic drugs and their FDA inspection track records.
Big Pharma Is Making Mexico Sick. Medicine and Supply Shortages Are Rampant.
Mexico manufactures medical devices and medicines, but the majority are exported, leaving residents facing shortages.
Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs
A ProPublica investigation found that for more than a decade, the FDA gave substandard factories banned from the United States a special pass to keep sending drugs to an unsuspecting…
Big Pharma Front Groups Muddle Debate Over Drug Prices, Patient Advocates Say
Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.
What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing
The gene therapy Zolgensma helped children born with a fatal disease, spinal muscular atrophy, grow up to run and play. But the cost was stunning: $2 million per dose.
Chris Hedges: The Killing of Brian Thompson
By Chris Hedges We do not yet know the motive for the assassination of UnitedHealthcare CEO Brian Thompson. But it would not surprise me if the killer stalked Thompson because…
RFK Jr., Physicians’ Pay Schedules, and the Elites’ Big Lie
The story of doctors’ pay is big money, more than is at stake in things like the expanded child tax credit or other issues that we often have major political…
US Drug Prices Still Far Higher Than Other Nations’ Even After Medicare Talks
The U.S. "has always accepted that we are the country that overpays relative to the rest of the world," said one health policy expert.
New York Times Sinks to New Low in Its Psychiatric Coverage
By Bruce E. Levine / CounterPunch For those familiar with the disastrous New York Times reporting of weapons of mass destruction (WMDs) in Iraq, it will be no great surprise…
Addressing Neglected Diseases: Can Non-Profits Bridge Pharma’s Investment Gap?
Programs for expedited review may be preferentially reducing the development costs for conditions with lesser disease burden, potentially making investments in addressing the most significant disease burdens even less appealing…
Public Pharma for Europe, a Game-Changer for Access to Medicines
A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits
Scientific Misconduct and Fraud: The Final Nail in Psychiatry’s Antidepressant Coffin
By Bruce E. Levine / CounterPunch “. . . if the major media picks up on this story, they will have the chance to report on what arguably is the…
Moderna Paid 400 Million to NIH
By John Campbell / YouTube Dr. John Campbell comments on Senator Rand Paul’s (R-KY) questioning of Moderna CEO Stéphane Bancel about Moderna’s $400 million payment to the National Institutes of…
Report Shows How Big Pharma Is Price Gouging Cancer Patients
"Cancer patients—the majority of whom are on Medicare—can face annual out-of-pocket costs of more than $16,500."
Sanders Excoriates ‘Unprecedented’ Greed of Big Pharma During Pandemic
The senator asked if it is "morally acceptable that tens of thousands of people die each year in this country because they cannot afford the medicine their doctors prescribe, while…